NAOV: NanoVibronix, Inc. Company Short-Term Debts

The asset value of NanoVibronix, Inc. (NAOV) tracked on the chart is currently at 0.00. NanoVibronix, Inc. (NAOV) generates revenue by supplying ultrasonic tissue regeneration systems, securing long-term income through service maintenance and the sale of components. Sales growth is driven by partnerships with medical centers to implement specialized dressings, while production processes are optimized via external contractors under strict patent supervision.

As a developer of patent-protected medtech devices, NanoVibronix, Inc. requires flexible financing to scale B2B sales. This metric aggregates all obligations with a maturity of up to one year, allowing for an assessment of liquidity and default risk in the absence of frequent reporting. A time-series analysis of short-term debt demonstrates a balance between financial stability and the use of leverage to enhance return on equity.